Currently, most studies have indicated that IQGAP3 functions as a promoter of tumorigenesis and is associated with a poor prognosis in various tumor types, including hepatocellular cancer, bladder cancer, lung cancer, and breast cancer [19, 22]. Here, IQGAP3 is linked to lung cancer.